Zachary Roberts, EVP of R&D at Allogene Therapeutics, Inc. (ALLO), sold 27,199 shares at $1.78 ($48K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Open-market sale of $48k ALLO by EVP of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALLO | SELL | 2025-02-05 | $32K | — | Filing → |